All Articles

Apollo Hospitals is launching 7-day routine care, a move tackling lifestyle diseases by removing weekday barriers. But can this bold model be sustained?

While investors watch for smartphone wins, Enovix quietly doubles its drone battery production, seizing a critical U.S. defense supply chain opportunity.

E-Power's joint venture is poised for elite 'Little Giant' status in China, a move validating its advanced battery materials for the AI and energy storage boom.

BTCS reports a 61% gross margin thanks to its Imperium DeFi unit, but a $35M net loss tells a different story. A deep dive into a high-stakes commercialization play.

New tobacco rules were meant to be clear, but a supply chain fumble has left small retailers with suspect inventory. It's a costly pattern of disconnect.

As U.S. agencies define a new "intermediate force" market, French innovator NETFORCE arrives with a patented stun glove and a plan to build in America.

Valor Exterior Partners' latest acquisition highlights a private equity-fueled strategy to consolidate local trades into a regional powerhouse.

An Indiana startup's AI scanners are winning awards by giving protein processors unprecedented control, recovering millions in lost yield and tackling food waste.

With $31M in new funding, an MIT spinoff is betting its truck-transportable nuclear reactors can solve the energy crisis for data centers and industry.

With Angela Kinsey as its 'Party Director,' Michaels bets on data and 'Partynomics' to capture the booming millennial at-home entertaining market.

Butterfield & Robinson's B Corp status isn't just a badge. It's a verifiable blueprint for ethical luxury in an industry rife with greenwashing.

Dr. Kate Teffer's move from federal agency architect to private sector strategist signals a new era in health innovation, where insider knowledge is key.

A new survey reveals a dangerous gap between confidence and reality in Medicare knowledge, exposing millions of Americans to uncapped financial risks.

As traditional banks retreat, firms like Crestline are stepping in. Their new $625M fund reveals a massive opportunity in Europe's lower-middle-market.

A $1M award for a novel drug targeting mitochondrial dysfunction is more than just funding; it's a bet on a new paradigm for fighting neurodegeneration.

A junior miner's modest acquisition in Oregon reveals the intense global scramble for critical minerals and the strategic chess match defining the sector.

An Ottawa developer is offering homes at 2019 prices, testing if government incentives and advanced manufacturing can finally deliver on affordability.

Health Union's annual awards do more than celebrate advocates; they signal the rise of a new economy where patient experience is a prized industry asset.

The upcoming Hardlines Supplier Event isn't just another trade show. It's a data-driven answer to the supply chain chaos plaguing a multi-billion dollar industry.

Two years after Hurricane Helene devastated their community, Warren Wilson College is using a $350,000 grant to turn disaster response into a curriculum for the future.